News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SMITH PATRICK F
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| SMITH PATRICK F (PRESIDENT, DRUG DEV SOLUTIONS) has filed a Form 4 on Certara, Inc.|
Txns:
| Granted 21,454 restricted stock units
@ $0 |
|
| 06/06/2023 |
4
| SMITH PATRICK F (PRESIDENT, INTEGRATED DRUG DEV) has filed a Form 4 on Certara, Inc.|
Txns:
| Sold 19,104 shares
@ $21.55, valued at
$411.7k
|
|
| 04/03/2023 |
4
| SMITH PATRICK F (PRESIDENT, INTEGRATED DRUG DEV) has filed a Form 4 on Certara, Inc.|
Txns:
| Paid exercise price by delivering 1,532 shares
@ $23.8, valued at
$36.5k
Paid exercise price by delivering 2,894 shares
@ $23.8, valued at
$68.9k
Exercised 8,646 restricted stock units
@ $0
Exercised 23,556 restricted stock units
@ $0 |
|
| 11/02/2022 |
4
| SMITH PATRICK F (PRESIDENT, INTEGRATED DRUG DEV) has filed a Form 4 on Certara, Inc.|
Txns:
| Paid exercise price by delivering 1,244 shares
@ $12.23, valued at
$15.2k
|
|
| 08/18/2022 |
4
| SMITH PATRICK F (PRESIDENT, INTEGRATED DRUG DEV) has filed a Form 4 on Certara, Inc.|
Txns:
| Sold 10,000 shares
@ $17.71, valued at
$177.1k
|
|
| 06/09/2022 |
4
| SMITH PATRICK F (PRESIDENT, INTEGRATED DRUG DEV) has filed a Form 4 on Certara, Inc.|
Txns:
| Sold 10,000 shares
@ $19.16, valued at
$191.6k
|
|
| 04/05/2022 |
4
| SMITH PATRICK F (PRESIDENT, INTEGRATED DRUG DEV) has filed a Form 4 on Certara, Inc.|
Txns:
| Paid exercise price by delivering 1,532 shares
@ $21.48, valued at
$32.9k
Sold 3,352 shares
@ $22.29, valued at
$74.7k
Granted 25,939 restricted stock units
@ $0 |
|
| 11/01/2021 |
4
| SMITH PATRICK F (PRESIDENT, INTEGRATED DRUG DEV) has filed a Form 4 on Certara, Inc.|
Txns:
| Granted 3,631 shares
@ $0 |
|
| 11/01/2021 |
3
| SMITH PATRICK F (PRESIDENT, INTEGRATED DRUG DEV) has filed a Form 3 on Certara, Inc. |
|
|